Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)
Not Applicable
Completed
- Conditions
- Ethylene glycol poisoning, methanol poisoning
- Registration Number
- JPRN-jRCT1080222765
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
The DUS did not reveal any new safety or efficacy concerns for fomepizole IV when used to treat Japanese patients with ethylene glycol and methanol poisonings.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 147
Inclusion Criteria
All patients who have been confirmed as administration of the drug
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method